In the mouse B16 melanoma model, irradiated tumor cells expressing GM-CSF, acted as a vaccine, inducing potent, long lasting T cell dependent tumor-specific immunity [152], identifying it as a promising immune modulatory candidate for arming oHSVs. This evidence concerns the gene CSF2 and neoplasm.